On this page
Signal check
What changed—and what was not tested
The report describes favorable observations in some patients and episodes of paroxysmal EEG activity in some cases. A small heterogeneous report cannot establish a low adverse-event rate or healthy-person safety.
[Use of semax at a follow-up of patients with posthypoxic encephalopathy]. (1999)
- Measured signal
- Clinical memory-related observations and EEG monitoring.
- Design
- Older comparative clinical report with limited methodological detail in the indexed abstract.
- Population or preparation
- 73 patients with varied posthypoxic encephalopathy; some had a persistent vegetative state.
- Reported change
- The report describes favorable observations in some patients and episodes of paroxysmal EEG activity in some cases.
- Inference boundary
- A small heterogeneous report cannot establish a low adverse-event rate or healthy-person safety.
The experimental design
Older comparative clinical report with limited methodological detail in the indexed abstract.
Who or what was studied
73 patients with varied posthypoxic encephalopathy; some had a persistent vegetative state.
The measurement
Clinical memory-related observations and EEG monitoring. For a separate account of ulcer healing over a short treatment observation period, read Semax in an older ulcer report. For a separate account of functional connectivity involving predefined amygdala and prefrontal regions, read Semax and Selank connectivity research.
The reported finding
The report describes favorable observations in some patients and episodes of paroxysmal EEG activity in some cases. Safety-relevant observations should not disappear because the article also contains a favorable efficacy statement. The available abstract does not provide the detail needed to determine individual causation, frequency or risk factors; uncertainty is the appropriate conclusion.
What the result cannot establish
A small heterogeneous report cannot establish a low adverse-event rate or healthy-person safety. The illness, co-interventions and monitoring context differ substantially from home use for focus. A clinician should interpret a neurological risk question, not a marketing comparison page. The consultation checklist can help you ask which part of this experimental result matches the preparation and goal under discussion.
A related comparison
Our Semax human safety guide explains the difference between a described event and a systematically measured event rate. It is especially relevant when a seller uses older clinical experience as broad reassurance.
Evidence index
Original research and documented service details.